First-Line Treatment for Alcohol Withdrawal Syndrome

Introduction to Treatment

Benzodiazepines are the gold standard first-line treatment for managing alcohol withdrawal symptoms due to their efficacy in reducing withdrawal symptoms and preventing seizures and delirium tremens, as recommended by the American Association for the Study of Liver Diseases 1, 2

Long-acting benzodiazepines, such as diazepam and chlordiazepoxide, provide better protection against seizures and delirium due to their longer duration of action 1
The American College of Clinical Pharmacology recommends diazepam 5-10 mg every 6-8 hours orally, intravenously, or intramuscularly for most patients 3
Chlordiazepoxide is recommended at a dose of 25-100 mg every 4-6 hours orally 2, 3

Short and intermediate-acting benzodiazepines, such as lorazepam, are preferred for high-risk patients, including those with advanced age, hepatic dysfunction, respiratory failure, obesity, and recent head trauma 2, 3
Lorazepam is typically administered at a dose of 1-4 mg every 4-8 hours (typically 6-12 mg/day) 2, 3

Thiamine must be administered to all patients with alcohol withdrawal to prevent Wernicke encephalopathy, at a dose of 100-300 mg/day 2, 3
Thiamine should be administered before any glucose-containing IV fluids 2
Carbamazepine can be used as an alternative for seizure prevention at a dose of 200 mg every 6-8 hours 2, 3
Haloperidol may be used carefully for agitation or psychotic symptoms not controlled by benzodiazepines at a dose of 0.5-5 mg every 8-12 hours 2

Inpatient treatment is recommended for patients with serious complications, high levels of recent drinking, history of withdrawal seizures or delirium tremens, co-occurring serious medical or psychiatric illness, and failure of outpatient treatment 2, 3

Disulfiram should be avoided in patients with severe alcoholic liver disease due to potential hepatotoxicity, as recommended by the American Association for the Study of Liver Diseases 1
Naltrexone is not recommended in patients with alcoholic liver disease due to potential hepatotoxicity, as recommended by the American Association for the Study of Liver Diseases 1